Simpson J F, Page D L
Division of Anatomic of Pathology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Curr Opin Oncol. 1997 Nov;9(6):512-9. doi: 10.1097/00001622-199711000-00004.
Our review of recent developments in breast cancer involving evaluation of cellular and tissue samples is targeted at indicators of elevated risk of sufficient magnitude to attain clinical significance; lesions unassociated with metastatic capacity but of sufficient risk to attain that capacity that formal treatment is necessary, ie, ductal carcinoma in situ; and indicators of good prognosis in invasive cancer. Ductal carcinoma in situ has been the subject of much recent discussion. We highlight particularly the area of stratification or classification within this group of lesions. The importance of the extensiveness of ductal carcinoma in situ in the prediction of local recurrence within the conserved breast is included. Also discussed are advances in diagnostic techniques, specifically core needle biopsies performed under mammographic and ultrasonographic guidance.
我们对乳腺癌近期进展的综述涉及细胞和组织样本评估,目标是具有足够程度升高风险且具有临床意义的指标;与转移能力无关但风险足够高以至于需要进行正规治疗的病变,即导管原位癌;以及浸润性癌的良好预后指标。导管原位癌是近期诸多讨论的主题。我们特别强调这组病变中的分层或分类领域。还包括导管原位癌范围在预测保乳局部复发中的重要性。此外,还讨论了诊断技术的进展,特别是在乳腺X线摄影和超声引导下进行的粗针活检。